These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9831899)

  • 21. Actions of the benzopyran compound terikalant on macroscopic currents in rat ventricular myocytes.
    McLarnon JG; Xu R
    J Pharmacol Exp Ther; 1995 Oct; 275(1):389-96. PubMed ID: 7562576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antiarrhythmic agent bertosamil induces inactivation of the sustained outward K+ current in human atrial myocytes.
    Tessier S; Rücker-Martin C; Macé L; Coraboeuf E; Mercadier JJ; Hatem SN
    Br J Pharmacol; 1997 Sep; 122(2):291-301. PubMed ID: 9313938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of tedisamil (KC-8857) on cardiac electrophysiology and ventricular fibrillation in the rabbit isolated heart.
    Chi L; Park JL; Friedrichs GS; Banglawala YA; Perez MA; Tanhehco EJ; Lucchesi BR
    Br J Pharmacol; 1996 Mar; 117(6):1261-9. PubMed ID: 8882624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of MS-551 and E-4031 on action potentials and the delayed rectifier K+ current in rabbit ventricular myocytes.
    Cheng J; Kamiya K; Kodama I; Toyama J
    Cardiovasc Res; 1996 Jun; 31(6):963-74. PubMed ID: 8759253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ambasilide prolongs the action potential and blocks multiple potassium currents in human atrium.
    Bosch RF; Milek IV; Popovic K; Mermi J; Mewis C; Kühlkamp V; Seipel L
    J Cardiovasc Pharmacol; 1999 May; 33(5):762-71. PubMed ID: 10226864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of alpha-allocryptopine on transient outward potassium current in rabbit ventricular myocytes.
    Li Y; Wang S; Liu Y; Li Z; Yang X; Wang H; Wen Y; Chen Y
    Cardiology; 2008; 111(4):229-36. PubMed ID: 18434730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salutary effect of tedisamil on post-ischemic recovery rat heart: involvement of sarcolemmal (Na,K)-ATPase.
    Dzurba A; Ziegelhöffer A; Okruhlicová L; Vrbjar N; Styk J
    Mol Cell Biochem; 2000 Dec; 215(1-2):129-33. PubMed ID: 11204448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tedisamil and dofetilide-induced torsades de pointes, rate and potassium dependence.
    Barrett TD; Hennan JK; Fischbach PS; O'Neill BP; Driscoll EM; Lucchesi BR
    Br J Pharmacol; 2001 Apr; 132(7):1493-500. PubMed ID: 11264243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of tedisamil on cardiovascular tissues isolated from normo- and hypertensive rats.
    Doggrell SA; Nand V
    J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):261-72. PubMed ID: 11584333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel antiarrhythmic drugs in atrial fibrillation: focus on tedisamil.
    Krishnamoorthy S; Lip GY
    Expert Opin Investig Drugs; 2009 Aug; 18(8):1191-6. PubMed ID: 19604120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tedisamil (Solvay).
    Flores NA
    Curr Opin Investig Drugs; 2001 Jan; 2(1):97-103. PubMed ID: 11527020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of ambasilide, a new class III agent, on plateau currents in isolated guinea pig ventricular myocytes: block of delayed outward potassium current.
    Zhang ZH; Follmer CH; Sarma JS; Chen F; Singh BN
    J Pharmacol Exp Ther; 1992 Oct; 263(1):40-8. PubMed ID: 1403801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined administration of an IK(ATP) activator and Ito blocker increases coronary flow independently of effects on heart rate, QT interval, and ischaemia-induced ventricular fibrillation in rats.
    Rees SA; Tsuchihashi K; Hearse DJ; Curtis MJ
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):343-9. PubMed ID: 7504122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of disopyramide on potassium currents in rabbit ventricular myocytes.
    Virág L; Varró A; Papp JG
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):268-75. PubMed ID: 9550298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The in vivo electrophysiological actions of the new potassium channel blockers, tedisamil and UK 68,798.
    Beatch GN; MacLeod BA; Abraham S; Walker MJ
    Proc West Pharmacol Soc; 1990; 33():5-8. PubMed ID: 2274546
    [No Abstract]   [Full Text] [Related]  

  • 36. Modulation of intracellular Ca(2+) concentration by tedisamil, a class III antiarrhythmic agent, in isolated heart preparation.
    Seki S; Tribulova N; Manoach M; Mochizuki S
    Life Sci; 2003 Aug; 73(14):1805-11. PubMed ID: 12888119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of 4-aminopyridine block of the transient outward K+ current in adult rat ventricular myocytes.
    Castle NA; Slawsky MT
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1450-9. PubMed ID: 8510021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological block of the slow component of the outward delayed rectifier current (I(Ks)) fails to lengthen rabbit ventricular muscle QT(c) and action potential duration.
    Lengyel C; Iost N; Virág L; Varró A; Lathrop DA; Papp JG
    Br J Pharmacol; 2001 Jan; 132(1):101-10. PubMed ID: 11156566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of class III antiarrhythmic drugs on transient outward and ultra-rapid delayed rectifier currents in human atrial myocytes.
    Feng J; Wang Z; Li GR; Nattel S
    J Pharmacol Exp Ther; 1997 Apr; 281(1):384-92. PubMed ID: 9103521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the potassium channel blocker tedisamil with the beta-adrenoceptor blocker esmolol and the calcium antagonist gallopamil in patients with coronary artery disease.
    Mitrovic V; Oehm E; Thormann J; Pitschner H; Haberbosch W
    Clin Cardiol; 1998 Jul; 21(7):492-502. PubMed ID: 9669058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.